We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+14.98%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$787M
AUM Growth
+$273M
Cap. Flow
+$216M
Cap. Flow %
27.52%
Top 10 Hldgs %
30.43%
Holding
459
New
34
Increased
332
Reduced
39
Closed
19

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.5M
2
NVDA icon
NVIDIA
NVDA
+$9.52M
3
NFLX icon
Netflix
NFLX
+$9.23M
4
GILD icon
Gilead Sciences
GILD
+$7.96M
5
AAPL icon
Apple
AAPL
+$7.69M

Top Sells

Rank Stock Value
1
EDV icon
Vanguard World Funds Extended Duration ETF
EDV
+$3.62M
2
WMT icon
Walmart Inc
WMT
+$2.88M
3
BABA icon
Alibaba
BABA
+$2.64M
4
XYZ
Block Inc
XYZ
+$2.4M
5
INTC icon
Intel
INTC
+$2.08M

Sector Composition

Rank Sector Weight
1 Technology 37.36%
2 Healthcare 29.98%
3 Consumer Discretionary 13.6%
4 Communication Services 8.97%
5 Financials 3.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REPL icon
376
Replimune Group
REPL
$1.28B
$96.5K 0.01%
11,808
+4,975
+73% +$40.8K
WBD icon
377
Warner Bros
WBD
$69.3B
$96.1K 0.01%
11,004
+6,072
+123% +$58.5K
KALV
378
DELISTED
KalVista Pharmaceuticals
KALV
$95.2K 0.01%
8,024
+4,043
+102% +$53.9K
MRNS
379
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$94.5K 0.01%
10,458
+4,151
+66% +$40.4K
ITOS
380
DELISTED
iTeos Therapeutics
ITOS
$93.8K 0.01%
6,877
+2,737
+66% +$29.8K
ADPT icon
381
Adaptive Biotechnologies
ADPT
$4.02B
$89.5K 0.01%
27,896
+11,149
+67% +$43.1K
HROW icon
382
Harrow
HROW
$1.48B
$89.2K 0.01%
6,745
+2,682
+66% +$28.6K
URGN icon
383
UroGen Pharma
URGN
$2.39B
$88.5K 0.01%
5,903
+2,328
+65% +$38.1K
CRBU icon
384
Caribou Biosciences
CRBU
$169M
$87.5K 0.01%
17,024
+6,798
+66% +$41.9K
TBPH icon
385
Theravance Biopharma
TBPH
$878M
$86K 0.01%
9,583
+3,824
+66% +$35.4K
WBA
386
DELISTED
Walgreens Boots Alliance
WBA
$84.4K 0.01%
3,890
+2,175
+127% +$48.3K
RVNC
387
DELISTED
Revance Therapeutics, Inc.
RVNC
$83.5K 0.01%
16,981
+6,826
+67% +$40.4K
MXCT icon
388
MaxCyte
MXCT
$136M
$83.3K 0.01%
19,884
+7,898
+66% +$37.1K
ABUS icon
389
Arbutus Biopharma
ABUS
$907M
$83.2K 0.01%
32,233
+12,833
+66% +$33.2K
AVXL icon
390
Anavex Life Sciences
AVXL
$316M
$80.3K 0.01%
15,773
+6,275
+66% +$35.3K
TERN
391
DELISTED
Terns Pharmaceuticals
TERN
$78K 0.01%
11,889
+4,742
+66% +$31K
MGTX icon
392
MeiraGTx Holdings
MGTX
$1.2B
$74.3K 0.01%
12,246
+4,892
+67% +$30.9K
THRD
393
DELISTED
Third Harmonic Bio
THRD
$73.5K 0.01%
7,784
+3,119
+67% +$30.3K
NAUT icon
394
Nautilus Biotechnolgy
NAUT
$114M
$70.8K 0.01%
24,076
+9,624
+67% +$27.3K
PGEN icon
395
Precigen
PGEN
$2.45B
$69.4K 0.01%
47,829
+19,041
+66% +$27.3K
SIRI icon
396
SiriusXM
SIRI
$9.59B
$67.2K 0.01%
1,733
+963
+125% +$45.8K
AMRN
397
Amarin Corp
AMRN
$297M
$66.1K 0.01%
3,709
+1,479
+66% +$31.6K
AVIR icon
398
Atea Pharmaceuticals
AVIR
$405M
$65.4K 0.01%
16,179
+6,526
+68% +$25.5K
DDL
399
Dingdong
DDL
$509M
$65.3K 0.01%
53,514
– –
ATAI icon
400
AtaiBeckley Inc
ATAI
$2.68B
$62.8K 0.01%
31,899
+12,693
+66% +$23.4K
14 15
16
17 18

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q1 2024 Portfolio in Review

As of Q1 2024, China Universal Asset Management Company held 459 positions worth $787M, up 53% from $514M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

China Universal Asset Management Company deployed $216M of net new capital in Q1 2024, opening 34 new positions and adding to 332 existing holdings. Its largest new stake was New Oriental: 27,235 shares worth $2.36M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard World Funds Extended Duration ETF, an estimated $3.62M trimmed.

  • China Universal Asset Management Company's largest Q1 2024 buy was New Oriental: 27,235 shares worth $2.36M.
  • China Universal Asset Management Company added most to Microsoft in Q1 2024, an estimated $17.5M increase.
  • China Universal Asset Management Company's biggest Q1 2024 reduction was Vanguard World Funds Extended Duration ETF, cutting an estimated $3.62M.
  • China Universal Asset Management Company fully exited Block Inc in Q1 2024, selling an estimated $2.4M.
  • China Universal Asset Management Company's ten largest holdings make up 30% of its $787M portfolio in Q1 2024.
  • China Universal Asset Management Company opened 34 new positions and closed 19 in Q1 2024.
  • China Universal Asset Management Company's portfolio value rose 53% quarter-over-quarter to $787M.

Based on China Universal Asset Management Company's 13F filing for Q1 2024, filed 29 Apr 2024.